Duloxetine vs Durvalumab

Duloxetine vs Durvalumab: Overview

This comparison examines the pharmacological differences between Duloxetine and Durvalumab.

Mechanism of Action

Duloxetine: Serotonin-norepinephrine reuptake inhibitor (SNRI).

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Duloxetine — 12 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Duloxetine — C18H19NOS.

Molecular Weight: Duloxetine — 297.4150 g/mol.

Type: Duloxetine — Small molecule; Durvalumab — Antibody.